I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-line treatment: a meta-analysis

被引：0
|
作者：
Zhong-Ke Chen
Jing Fan
Fen-Qiang Li
Shi-Yan Zhou
Yuan-Shun Xu
机构：
[1] Affiliated Hospital of Gansu Medical College,Department of Interventional Therapy
[2] Lanzhou University First Affiliated Hospital,Interventional Radiology Department
[3] Xuzhou Central Hospital,Radiology Department
来源：
Journal of Cardiothoracic Surgery | / 17卷
关键词：
I-125 seed; Non-small-cell lung cancer; Progressive; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-line treatment: a meta-analysis
    Chen, Zhong-Ke
    Fan, Jing
    Li, Fen-Qiang
    Zhou, Shi-Yan
    Xu, Yuan-Shun
    JOURNAL OF CARDIOTHORACIC SURGERY, 2022, 17 (01)
  • [2] PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis
    Garcia-Gonzalez, Jorge
    Ruiz-Banobre, Juan
    Afonso-Afonso, Francisco J.
    Amenedo-Gancedo, Margarita
    Areses-Manrique, Maria del Carmen
    Campos-Balea, Begona
    Casal-Rubio, Joaquin
    Fernandez-Nunez, Natalia
    Firvida Perez, Jose Luis
    Lazaro-Quintela, Martin
    Perez Parente, Diego
    Crama, Leonardo
    Ruiz-Gracia, Pedro
    Santome-Couto, Lucia
    Leon-Mateos, Luis
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 13
  • [3] Effects of adding necitumumab to first-line chemotherapy in patients with stage IV non-small-cell lung cancer: Meta-analysis
    Ilic, Irena
    Sipetic, Sandra
    Grujicic, Jovan
    Ilic, Milena
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (06) : 1331 - 1342
  • [4] Antiangiogenic Agents Combined with Chemotherapy in the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Overall and Histology Subgroup-Specific Meta-Analysis
    Zhang, Linlin
    Cao, Feifei
    Wang, Yan
    Wang, Shuang
    Zhong, Diansheng
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (12) : 710 - 718
  • [5] First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysis
    Kim, Ryul
    Keam, Bhumsuk
    Hahn, Seokyung
    Ock, Chan-Young
    Kim, Miso
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    CLINICAL LUNG CANCER, 2019, 20 (05) : 331 - +
  • [6] Erlotinib in the first-line treatment of non-small-cell lung cancer
    D'Arcangelo, Manolo
    Cappuzzo, Federico
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (05) : 523 - 533
  • [7] Radioactive seeds insertion with chemotherapy for advanced non-small-cell lung cancer: A meta-analysis
    Wu, Hong
    Li, Lei
    Yang, Jing
    Yang, Zhi-Min
    CLINICAL RESPIRATORY JOURNAL, 2021, 15 (02) : 187 - 195
  • [8] Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer
    Hayashi, H.
    Okamoto, I.
    Morita, S.
    Taguri, M.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2012, 23 (06) : 1537 - 1541
  • [9] Effectiveness and Safety of Adding Bevacizumab to Platinum-Based Chemotherapy as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis
    Liu, Yi
    Li, Hui-Min
    Wang, Ran
    FRONTIERS IN MEDICINE, 2021, 8
  • [10] Network Meta-Analysis of First-Line and Maintenance Regimens in EGFR Mutated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    De Lima Lopes, Gilberto
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1224 - S1225
12345